The initial findings that BDNF rescues injury-induced motor neurons death and motor dysfunction in the wobbler mouse model of motor neuron disease (Sendtner et al., 1992; Yan et al., 1992; Ikeda et al., 1995) provided the rationale for the clinical use of BDNF in ALS patients. This evidence concerns the gene BDNF and motor neuron disorder.